186 related articles for article (PubMed ID: 10774591)
1. Inhibitory effect of cycloSaligenyl-nucleoside monophosphates (cycloSal-NMP) of acyclic nucleoside analogues on HSV-1 and EBV.
Meerbach A; Klöcking R; Meier C; Lomp A; Helbig B; Wutzler P
Antiviral Res; 2000 Jan; 45(1):69-77. PubMed ID: 10774591
[TBL] [Abstract][Full Text] [Related]
2. Chemistry and anti-herpes simplex virus type 1 evaluation of cycloSal-nucleotides of acyclic nucleoside analogues.
Meier C; Habel L; Haller-Meier F; Lomp A; Herderich M; Klöcking R; Meerbach A; Wutzler P
Antivir Chem Chemother; 1998 Sep; 9(5):389-402. PubMed ID: 9875392
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of cycloSal-nucleoside monophosphates and polyhydroxycarboxylates against orthopoxviruses.
Sauerbrei A; Meier C; Meerbach A; Schiel M; Helbig B; Wutzler P
Antiviral Res; 2005 Sep; 67(3):147-54. PubMed ID: 16076502
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory efficacy of cyclosal-nucleoside monophosphates of aciclovir and brivudin on DNA synthesis of orthopoxvi ruses.
Sauerbrei A; Meier C; Meerbach A; Wutzler P
Antivir Chem Chemother; 2006; 17(1):25-31. PubMed ID: 16542003
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir.
Balzarini J; Haller-Meier F; De Clercq E; Meier C
Antivir Chem Chemother; 2001 Sep; 12(5):301-6. PubMed ID: 11900349
[TBL] [Abstract][Full Text] [Related]
7. Recombinant herpes simplex virus type 1 strains with targeted mutations relevant for aciclovir susceptibility.
Brunnemann AK; Liermann K; Deinhardt-Emmer S; Maschkowitz G; Pohlmann A; Sodeik B; Fickenscher H; Sauerbrei A; Krumbholz A
Sci Rep; 2016 Jul; 6():29903. PubMed ID: 27426251
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of novel nucleoside and nucleotide analogues on Epstein-Barr virus replication.
Meerbach A; Holý A; Wutzler P; De Clercq E; Neyts J
Antivir Chem Chemother; 1998 May; 9(3):275-82. PubMed ID: 9875407
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of anise oil, dwarf-pine oil and chamomile oil against thymidine-kinase-positive and thymidine-kinase-negative herpesviruses.
Koch C; Reichling J; Kehm R; Sharaf MM; Zentgraf H; Schneele J; Schnitzler P
J Pharm Pharmacol; 2008 Nov; 60(11):1545-50. PubMed ID: 18957177
[TBL] [Abstract][Full Text] [Related]
10. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
[TBL] [Abstract][Full Text] [Related]
11. Activity of penciclovir against Epstein-Barr virus.
Bacon TH; Boyd MR
Antimicrob Agents Chemother; 1995 Jul; 39(7):1599-602. PubMed ID: 7492112
[TBL] [Abstract][Full Text] [Related]
12. The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production.
Meng Q; Hagemeier SR; Fingeroth JD; Gershburg E; Pagano JS; Kenney SC
J Virol; 2010 May; 84(9):4534-42. PubMed ID: 20181711
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-HSV activity of tricyclic penciclovir and hydroxybutylguanine derivatives.
Mohammed AF; Andrei G; Hayallah AM; Abdel-Moty SG; Snoeck R; Simons C
Bioorg Med Chem; 2019 Mar; 27(6):1023-1033. PubMed ID: 30738653
[TBL] [Abstract][Full Text] [Related]
14. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses.
Hakimelahi GH; Ly TW; Moosavi-Movahedi AA; Jain ML; Zakerinia M; Davari H; Mei HC; Sambaiah T; Moshfegh AA; Hakimelahi S
J Med Chem; 2001 Oct; 44(22):3710-20. PubMed ID: 11606136
[TBL] [Abstract][Full Text] [Related]
16. Phosphoramidate derivatives of acyclovir: synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro.
Zakirova NF; Shipitsyn AV; Jasko MV; Prokofjeva MM; Andronova VL; Galegov GA; Prassolov VS; Kochetkov SN
Bioorg Med Chem; 2012 Oct; 20(19):5802-9. PubMed ID: 22954898
[TBL] [Abstract][Full Text] [Related]
17. Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.
Yang L; Mo X; Yang H; Dai H; Tan F
J Mol Model; 2014 Jul; 20(7):2321. PubMed ID: 24961898
[TBL] [Abstract][Full Text] [Related]
18. Activity of penciclovir in antiviral assays against herpes simplex virus.
Bacon TH; Howard BA; Spender LC; Boyd MR
J Antimicrob Chemother; 1996 Feb; 37(2):303-13. PubMed ID: 8707740
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic genotoxicity of anti-herpes purine nucleoside analogues in CHO cells expressing the thymidine kinase gene of herpes simplex virus type 1: comparison of ganciclovir, penciclovir and aciclovir.
Thust R; Tomicic M; Klöcking R; Wutzler P; Kaina B
Mutagenesis; 2000 Mar; 15(2):177-84. PubMed ID: 10719044
[TBL] [Abstract][Full Text] [Related]
20. The N-7-substituted acyclic nucleoside analog 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine is a potent and selective inhibitor of herpesvirus replication.
Neyts J; Andrei G; Snoeck R; Jähne G; Winkler I; Helsberg M; Balzarini J; De Clercq E
Antimicrob Agents Chemother; 1994 Dec; 38(12):2710-6. PubMed ID: 7695251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
